STRATA Skin Sciences, Inc.
- Jurisdiction
United States - LEI
529900JXBTG5OB59PM04 - ISIN
US86272A3059 (SSKN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. Read full profile
Fundamentals
- Net revenue
€28.02M - Gross margin
57.9% - EBIT
-€8.63M - EBIT margin
-30.8% - Net income
-€9.84M - Net margin
-35.1%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: August 13, 2025 (Q2 2025)